Skip to content
AwardedSpainGoods€401,940

Suministro del principio activo Gozetotida 25 microgramos, equipo reactivo para preparación radio farmacéutica, con destino al Servicio de Medicina Nuclear del Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria

Published
Published 17 February 2026
Deadline
Closed 18 March 2026

Overview

The Complejo Hospitalario Universitario Insular Materno Infantil has awarded a contract to NOVARTIS FARMACEUTICA S.A. for the supply of Gozetotide 25 micrograms active pharmaceutical ingredient and reactive equipment for radiopharmaceutical preparation for the Nuclear Medicine Service. The contract was awarded on 25 May 2026 for 182,700 EUR.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€401,940
Procedure
Open
Published
17 February 2026
Deadline
Closed
Classification (CPV)
Isotopic reagents

Award outcome

Awarded value
€182,700
Award date
25 May 2026
Contract period
— → 20 May 2027
Winner
  • NOVARTIS FARMACEUTICA S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    29 June 2026

  2. Contract Notice

    17 February 2026

Contracting authority

  • Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil

    Procuring entity

    Las Palmas de Gran Canaria, Spain

    ID_PLATAFORMA: 21063710150131

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro del principio activo Gozetotida 25 microgramos, equipo reactivo para preparación radio farmacéutica, con destino al Servicio de Medicina Nuclear del Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria — won by NOVARTIS FARMACEUTICA S.A. — Skim